Effector Therapeuticsincis A Clinical Stage Biopharmaceutical Company Based In San Diegocaliforniafounded In 2012The Company Is Dedicated To Developing Targeted Therapies For Cancer And Other Challenging Diseaseswith A Focus On Innovative Small Molecule Therapeuticsits Research Is Rooted In The Work Of Prominent Scientists From The University Of Californiasan Francisco The Company Specializes In Selective Translation Regulator Inhibitorsstrisaimed At Treating Cancerthese Inhibitors Target Specific Pathways Involved In Cancer Progressionwith The Goal Of Improving Patient Outcomeseffector Therapeutics Has Advanced Several Lead Compounds Through Preclinical And Clinical Testinga Notable Partnership With Pfizer Includes A $507 Million Agreement To Develop Small Molecule Inhibitors For Solid Tumors
